Despite no overt clinical phenotype at the earliest stages of infection amongst the AIMp1−/− survivors, AIMp1 deficiency mediated significant effects on innate and adaptive immune responses on days 7 and 15 postinfection. The gene discussed is AIMP1; the disease is infection.